Derby & Company’s Bio-Rad Laboratories Class A BIO Stock Holding History

Derby & Company’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$970K	Hold	1,300	–	–	0.2%	42
2021 Q2	$838K	Hold	1,300	–	–	0.17%	44
2021 Q1	$743K	Hold	1,300	–	–	0.17%	45
2020 Q4	$758K	Hold	1,300	–	–	0.19%	37
2020 Q3	$670K	Hold	1,300	–	–	0.19%	36
2020 Q2	$587K	Buy	+1,300	New	+$574K	0.19%	36

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Derby & Company's BIO Position: Q3 2021 in Review

Derby & Company held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2021 at 1,300 shares worth $970K. The position accounts for 0.2% of the portfolio, ranked #42.

Derby & Company first reported a position in BIO in Q2 2020 and has held it in 6 quarters since. 508 funds tracked by Wall St. Rank hold BIO as of Q3 2021.

Derby & Company held 1,300 shares of Bio-Rad Laboratories Class A worth $970K as of Q3 2021.
Derby & Company left its Bio-Rad Laboratories Class A share count unchanged in Q3 2021.
Bio-Rad Laboratories Class A made up 0.2% of Derby & Company's portfolio in Q3 2021, its #42 holding.
Derby & Company first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and has held it in 6 quarters since.
508 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2021.

Based on Derby & Company's 13F filing for Q3 2021, filed 12 Nov 2021.